RxDoctor Payments Data

Antonio Castellvi, MD

Family Medicine · Tampa, FLNPI 1700114527

Payments from drug & device makers

$9,866in general payments, 2019–2025

Across 558 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$916
  • Pfizer$739
  • Amarin Pharma, Inc.$661
  • Lilly USA, LLC$658
  • Amgen$567
  • plus $5K from 49 others

What the payments were for

  • Food & beverage$9,854100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,866 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$21,532
Medicare patients
63
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$52,556
EliquisApixaban28$32,909
TrulicityDulaglutide12$19,075
JardianceEmpagliflozin17$18,795
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$13,587
EntrestoSacubitril/Valsartan17$11,492
FarxigaDapagliflozin Propanediol14$10,448
SynthroidLevothyroxine Sodium21$2,432
Atorvastatin Calcium124$1,203
Rosuvastatin Calcium53$696
Losartan Potassium54$644
Levothyroxine Sodium50$599
Simvastatin35$562
Alprazolam56$530
Tamsulosin Hcl38$421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,314$52,55643 claims
PfizerEliquis$739$32,90928 claims
Lilly USA, LLCTrulicity$658$19,07512 claims
Boehringer IngelheimJardiance$186$18,79517 claims
GSKTrelegy Ellipta$399$13,58712 claims
NovartisEntresto$70$11,49217 claims
AstraZenecaFarxiga$477$10,44814 claims
AbbVieSynthroid$916$2,43221 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$12$59950 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →